Molecular Targeting of Intracellular Bacteria by Homotypic Recognizing Nanovesicles for Infected Pneumonia Treatment

Area of Science:

• Biomedical Engineering
• Nanomedicine
• Infectious Diseases

Background:

• Pneumonia treatment faces challenges with intracellular bacteria and cytokine storms.
• Existing antibiotic strategies have limited efficacy against resistant pathogens.
• Antibiotic resistance is a growing global health concern.

Purpose of the Study:

• To develop an exosome-based drug delivery system for enhanced pneumonia treatment.
• To improve antibiotic targeting of intracellular bacteria within macrophages.
• To mitigate the inflammatory response associated with pneumonia.

Main Methods:

• Engineered M2 macrophage-derived exosomes (Exos) to encapsulate antibiotics (antibiotics@Exos).
• Utilized homotypic recognition for specific delivery to infected macrophages.
• Evaluated the anti-inflammatory and bactericidal effects in a mouse model of acute lung injury.

Main Results:

• Antibiotics@Exos demonstrated significant intracellular bactericidal activity.
• M2-derived vesicles reprogrammed inflammatory macrophages to an anti-inflammatory phenotype.
• Treatment reduced inflammatory cell infiltration, cytokine storm, and lung injury in mice.

Conclusions:

• The developed antibiotics@Exos system offers a promising strategy for pneumonia treatment.
• This bioactive vesicle system overcomes limitations of traditional antibiotic therapies.
• It presents a novel approach for managing serious infectious diseases like acute pneumonia.